OTCMKTS:SAUHY - Straumann Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 7
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$81.34
▲ +2.52 (3.20%)

This chart shows the closing price for SAUHY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Straumann Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SAUHY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SAUHY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Straumann in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $81.34.

This chart shows the closing price for SAUHY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 investment analysts is to hold stock in Straumann. This rating has held steady since March 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 2 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 2 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 2 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/5/2021Berenberg BankReiterated RatingHold
5/3/2021UBS GroupReiterated RatingNeutral
4/30/2021Credit Suisse GroupReiterated RatingOutperform
4/30/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
4/13/2021Berenberg BankReiterated RatingHold
2/18/2021UBS GroupReiterated RatingNeutral
2/17/2021Credit Suisse GroupReiterated RatingOutperform
2/16/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
2/8/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
1/20/2021Berenberg BankReiterated RatingHold
1/13/2021Credit Suisse GroupReiterated RatingOutperform
1/11/2021Stifel NicolausDowngradeBuy ➝ Hold
12/9/2020Morgan StanleyReiterated RatingUnderweight
11/23/2020Credit Suisse GroupReiterated RatingOutperform
10/29/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
10/14/2020Berenberg BankReiterated RatingHold
10/6/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
10/5/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
8/24/2020Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
8/17/2020Berenberg BankReiterated RatingHold
8/14/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
8/7/2020Berenberg BankReiterated RatingHold
7/2/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
6/30/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
5/29/2020Morgan StanleyDowngradeOverweight ➝ Underweight
5/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
5/15/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
4/27/2020Berenberg BankReiterated RatingHold
4/17/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell
4/9/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/1/2020JPMorgan Chase & Co.Reiterated RatingNeutral
1/31/2020Berenberg BankDowngradeHold ➝ Sell
1/30/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy
1/11/2019Jefferies Financial GroupUpgradeHold ➝ Buy
12/10/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight
10/3/2017CitigroupUpgradeSell ➝ Neutral
8/22/2017Kepler Capital MarketsUpgradeReduce ➝ Hold
(Data available from 6/24/2016 forward)
Straumann logo
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implant systems, biomaterials, CADCAM prosthetics, digital equipment, software, clear aligner systems, and various materials for dental applications. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides biomaterials, such as bone augmentation materials, membranes, fleeces, and sponges; ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Read More

Today's Range

Now: $81.34
Low: $80.80
High: $81.34

50 Day Range

MA: $75.02
Low: $66.67
High: $82.80

52 Week Range

Now: $81.34
Low: $40.70
High: $82.80

Volume

6,622 shs

Average Volume

13,422 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Straumann?

The following Wall Street analysts have issued research reports on Straumann in the last twelve months: Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Stifel Nicolaus, and UBS Group AG.
View the latest analyst ratings for SAUHY.

What is the current price target for Straumann?

0 Wall Street analysts have set twelve-month price targets for Straumann in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Straumann in the next year.
View the latest price targets for SAUHY.

What is the current consensus analyst rating for Straumann?

Straumann currently has 1 sell rating, 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SAUHY, but not buy more shares or sell existing shares.
View the latest ratings for SAUHY.

What other companies compete with Straumann?

How do I contact Straumann's investor relations team?

The company's listed phone number is (161) 965-1111. The official website for Straumann is www.straumann.com.